Skip to main content
Premium Trial:

Request an Annual Quote

BillionToOne, Sugentech Coronavirus Tests Get FDA Emergency Use Authorization

NEW YORK — The US Food and Drug Administration last week granted separate Emergency Use Authorizations for BillionToOne's Sanger sequencing-based SARS-CoV-2 test, as well as an antibody test for the virus developed by South Korean diagnostics firm Sugentech.

BillionToOne's qSanger-COVID-19 test is designed to detect viral nucleic acid in upper respiratory specimens and requires no RNA extraction. As described in a manuscript released by the Menlo Park, California-based company in April, the test involves sequencing a single amplicon from the viral genome along with an RNA spike-in control, followed by data analysis with proprietary software.

The test may be performed by any lab certified to perform high-complexity tests. BillionToOne said that it began international distribution of the test in May and that it has been adopted by Brazilian medical diagnostics lab DASA.

Sugentech's SGTi-flex COVID-19 IgG is designed to detect immunoglobulin G antibodies against SARS-CoV-2 in serum, plasma, and venous whole blood. Results are provided within 10 minutes.

The test may be performed by any lab certified to perform moderate- or high-complexity tests.

The Scan

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.

Sequencing Analysis Examines Gene Regulatory Networks of Honeybee Soldier, Forager Brains

Researchers in Nature Ecology & Evolution find gene regulatory network differences between soldiers and foragers, suggesting bees can take on either role.

Analysis of Ashkenazi Jewish Cohort Uncovers New Genetic Loci Linked to Alzheimer's Disease

The study in Alzheimer's & Dementia highlighted known genes, but also novel ones with biological ties to Alzheimer's disease.

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.